---
id: spontaneous-bacterial-peritonitis_090
category: clinical_syndromes
tags: [SBP, ascites, cirrhosis, cefotaxime, PMN-count, prophylaxis]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## Spontaneous Bacterial Peritonitis (SBP)

**Q:** What are the diagnostic criteria, empiric treatment, and prophylaxis strategies for spontaneous bacterial peritonitis in patients with cirrhosis and ascites?

**A:**

**Definition:**
- **Spontaneous Bacterial Peritonitis (SBP):** Infection of ascitic fluid **WITHOUT an obvious intra-abdominal source** (no perforation, abscess, etc.)
- **Occurs in patients with cirrhosis and ascites**

---

## EPIDEMIOLOGY

**Incidence:**
- **10-30% of hospitalized cirrhotic patients with ascites**
- **1-year probability of SBP:** 10-25%

**Mortality:**
- **In-hospital mortality:** 20-40%
- **1-year mortality:** 50-70% (even if treated successfully)

**Key Point:** **SBP = high mortality** (20-40% in-hospital, 50-70% at 1 year)

---

## PATHOGENESIS

**Mechanism:**
- **Bacterial translocation** from GI tract → Mesenteric lymph nodes → Bloodstream → Ascitic fluid
- **Impaired immune defenses** in cirrhosis (low complement, low opsonic activity)

**Risk Factors:**
- **Low ascitic fluid protein** (<1.5 g/dL - "low-protein ascites")
- **Prior SBP** (69% recurrence rate at 1 year without prophylaxis)
- **Variceal hemorrhage** (GI bleeding → bacterial translocation)
- **Advanced cirrhosis** (Child-Pugh B/C)
- **Proton pump inhibitors** (↑ bacterial overgrowth)

**Key Point:** **Low ascitic fluid protein (<1.5 g/dL) = #1 risk factor** for SBP

---

## MICROBIOLOGY

**Most Common Organisms:**

| **Organism** | **Frequency** | **Key Features** |
|--------------|---------------|------------------|
| ***E. coli*** | **40-50%** (#1) | Gram-negative bacilli |
| ***Klebsiella pneumoniae*** | **10-15%** | Gram-negative bacilli |
| ***Streptococcus pneumoniae*** | **10-15%** | Gram-positive cocci |
| ***Streptococcus* species (viridans, other)** | **10-15%** | Gram-positive cocci |
| ***Enterococcus* species** | **5-10%** | Gram-positive cocci |

**Key Point:** ***E. coli* = #1 organism** (40-50%), **Monomicrobial** (>90% of cases)

---

## CLINICAL PRESENTATION

**Symptoms (OFTEN SUBTLE):**
- **Fever** (50-70%)
- **Abdominal pain/tenderness** (50%)
- **Altered mental status** (encephalopathy - 50%)
- **Diarrhea**
- **Ileus**
- **Renal failure** (hepatorenal syndrome)

**Key Point:** **>30% are ASYMPTOMATIC** (SBP can be completely asymptomatic)

**Low Threshold for Diagnostic Paracentesis:**
- **ALL hospitalized cirrhotic patients with ascites** should have diagnostic paracentesis on admission
- **Low threshold for repeat paracentesis** if clinical deterioration

---

## DIAGNOSIS

---

### **Diagnostic Paracentesis:**

**Indication:**
- **ALL cirrhotic patients with ascites** admitted to hospital
- **ANY clinical deterioration** (fever, abdominal pain, encephalopathy, renal failure, GI bleeding)

**Technique:**
- **Site:** Left lower quadrant (avoid midline - collaterals), avoid obvious dilated veins
- **Coagulopathy:** Paracentesis is safe even with INR >2 or platelets <50,000 (do NOT need to correct)

---

### **Ascitic Fluid Studies:**

**Routine Tests:**
- **Cell count with differential** (MOST IMPORTANT)
- **Albumin** (for SAAG calculation)
- **Total protein**
- **Gram stain, bacterial culture** (inoculate blood culture bottles at bedside)
- **Glucose** (optional)
- **LDH** (optional)

**Additional Tests (If Indicated):**
- **Cytology** (if concern for malignancy)
- **Amylase** (if concern for pancreatic ascites)
- **AFB smear/culture** (if concern for TB peritonitis)

---

### **Diagnostic Criteria for SBP:**

**SBP Diagnosis:**
- **Ascitic fluid PMN count ≥250 cells/μL**
- **Positive culture** (monomicrobial - typically 1 organism)
- **NO evidence of intra-abdominal surgical source** (no perforation, abscess, etc.)

**Key Point:** **PMN ≥250 cells/μL = SBP** (treat immediately, do NOT wait for culture)

---

### **Variants of SBP:**

| **Variant** | **PMN Count** | **Culture** | **Management** |
|-------------|---------------|-------------|----------------|
| **Classic SBP** | **≥250 cells/μL** | **Positive** (monomicrobial) | Treat with antibiotics |
| **Culture-Negative Neutrocytic Ascites (CNNA)** | **≥250 cells/μL** | **Negative** | Treat as SBP (same antibiotics) |
| **Bacterascites** | **<250 cells/μL** | **Positive** (monomicrobial) | **Repeat paracentesis** (if symptomatic → Treat; if asymptomatic → Observe) |
| **Secondary Bacterial Peritonitis** | **≥250 cells/μL** | **Polymicrobial** OR **Anaerobes** | **Urgent imaging** (CT) + **Surgery consult** (perforated viscus) |

**Key Point:** **CNNA (PMN ≥250, culture negative) = treat as SBP** (culture may be false negative)

---

### **Secondary Bacterial Peritonitis (NOT SBP):**

**Suspect if:**
- **Polymicrobial culture** (≥2 organisms)
- **Anaerobes** on culture
- **Ascitic fluid protein >1 g/dL** (typically low in SBP)
- **Ascitic fluid glucose <50 mg/dL**
- **Ascitic fluid LDH > serum LDH**
- **No response to antibiotics** (within 48h)

**Runyon Criteria (≥2 = Secondary Peritonitis):**
- **Protein >1 g/dL**
- **Glucose <50 mg/dL**
- **LDH > upper limit of normal serum**

**Management:**
- **Urgent CT abdomen/pelvis** (look for perforation, abscess)
- **Surgery consult**
- **Broad-spectrum antibiotics** (cover anaerobes)

**Key Point:** **Polymicrobial or anaerobes = secondary peritonitis** (NOT SBP) → Image + surgery consult

---

## TREATMENT

---

### **Empiric Antibiotic Therapy (Start IMMEDIATELY):**

**First-Line:**

| **Agent** | **Dosing** | **Duration** |
|-----------|------------|--------------|
| **Cefotaxime** (preferred) | **2g IV q8h** | **5 days** (if clinical improvement) |
| **OR Ceftriaxone** | **2g IV q24h** | **5 days** |

**Alternative (PCN Allergy):**
- **Fluoroquinolone** (ciprofloxacin 400 mg IV q12h OR levofloxacin 750 mg IV q24h) - if no prior quinolone prophylaxis

**Key Point:** **Cefotaxime 2g IV q8h = first-line** (5 days if clinical improvement)

---

**Duration:**
- **5 days** (if clinical improvement + PMN count decreased by ≥25% at 48h)
- **Extend to 7-10 days** if slow response

**Response Assessment:**
- **Repeat paracentesis at 48h** (PMN count should ↓ by ≥25%)
- **If PMN count NOT decreasing** → Consider secondary peritonitis (image + surgery consult)

---

### **Targeted Therapy (After Culture Results):**

| **Organism** | **Regimen** |
|--------------|-------------|
| ***E. coli*, *Klebsiella*** (Gram-negative) | **Cefotaxime** OR **Ceftriaxone** (as above) |
| ***Streptococcus* species** | **Cefotaxime** OR **Penicillin G** 4 million units IV q4h |
| ***Enterococcus*** | **Ampicillin** 2g IV q4h OR **Vancomycin** 15 mg/kg IV q12h (if VRE) |

---

### **Adjunctive Albumin (REDUCE Renal Failure, IMPROVE Survival):**

**Indication:**
- **ALL patients with SBP**

**Dosing:**
- **1.5 g/kg IV within 6 hours of diagnosis**
- **THEN 1 g/kg IV on day 3**

**Benefit:**
- **Reduces renal failure** (hepatorenal syndrome) - from 30% → 10%
- **Improves survival** - from 29% → 10% mortality

**Key Point:** **Albumin 1.5 g/kg at diagnosis + 1 g/kg day 3** (reduces renal failure, improves survival)

---

## PROPHYLAXIS

**Goal:** Prevent first or recurrent SBP

---

### **Primary Prophylaxis (Prevent First Episode):**

**Indications:**
- **Low ascitic fluid protein (<1.5 g/dL)** PLUS ≥1 of:
  - Child-Pugh score ≥9 with bilirubin ≥3 mg/dL
  - Serum creatinine ≥1.2 mg/dL
  - BUN ≥25 mg/dL
  - Serum sodium ≤130 mEq/L

**OR**
- **Acute variceal hemorrhage** (all patients during bleeding episode)

---

**Regimen:**

**Acute Variceal Hemorrhage:**
- **Ceftriaxone** 1g IV q24h x **7 days** (during active bleeding)
- **OR Norfloxacin** 400 mg PO BID x 7 days (alternative)

**Long-Term Primary Prophylaxis:**
- **Norfloxacin** 400 mg PO daily (indefinitely)
- **OR TMP-SMX** DS 1 tab PO daily (alternative)
- **OR Ciprofloxacin** 750 mg PO weekly (alternative)

**Key Point:** **Primary prophylaxis if low protein ascites (<1.5 g/dL) + advanced cirrhosis**

---

### **Secondary Prophylaxis (Prevent Recurrence):**

**Indication:**
- **Prior episode of SBP** (69% recurrence rate at 1 year without prophylaxis)

**Regimen:**
- **Norfloxacin** 400 mg PO daily (indefinitely OR until liver transplant/death)
- **OR TMP-SMX** DS 1 tab PO daily
- **OR Ciprofloxacin** 750 mg PO weekly

**Duration:**
- **Lifelong** (or until liver transplant, resolution of ascites, death)

**Key Point:** **Secondary prophylaxis MANDATORY** after first SBP episode (69% recurrence without prophylaxis)

---

## MONITORING & FOLLOW-UP

**Repeat Paracentesis at 48 Hours:**
- **Check PMN count** (should ↓ by ≥25%)
- **If NOT improving:** Consider secondary peritonitis (CT + surgery consult)

**Clinical Response:**
- **Improvement expected within 48-72 hours** (decreased fever, abdominal pain, improved mental status)

---

## PROGNOSIS

**Mortality:**
- **In-hospital:** 20-40%
- **1-year mortality:** 50-70% (even if SBP treated successfully)

**Recurrence:**
- **69% recurrence at 1 year** (without prophylaxis)
- **20% recurrence at 1 year** (with prophylaxis)

**Predictors of Poor Outcome:**
- **Renal failure** (hepatorenal syndrome)
- **Child-Pugh C cirrhosis**
- **Delayed treatment**

**Key Point:** **SBP = poor prognosis** (even with treatment, 50-70% mortality at 1 year)

**Liver Transplant Evaluation:**
- **SBP is indication to refer for liver transplant evaluation**

---

**Mnemonic: "PMN ≥250 = SBP"**
- **P**MN count
- **≥250** cells/μL
- **S**BP diagnosis (treat immediately)

**Mnemonic: "CAPE for SBP Treatment"**
- **C**efotaxime (first-line)
- **A**lbumin (1.5 g/kg at diagnosis + 1 g/kg day 3)
- **P**rophylaxis (secondary - norfloxacin after first episode)
- **E**valuate for transplant

**Mnemonic: "Low Protein = Prophylaxis"**
- **L**ow ascitic fluid protein (<1.5 g/dL)
- **P**rophylaxis indicated (primary)

**Clinical Pearls:**
- **SBP = PMN ≥250 cells/μL** in ascitic fluid (treat immediately, do NOT wait for culture)
- **>30% are asymptomatic** (low threshold for diagnostic paracentesis)
- **ALL hospitalized cirrhotic patients with ascites** should have paracentesis on admission
- ***E. coli* = #1 organism** (40-50%), monomicrobial in >90%
- **Cefotaxime 2g IV q8h x 5 days = first-line** treatment
- **Albumin 1.5 g/kg at diagnosis + 1 g/kg day 3** (reduces renal failure 30%→10%, improves survival)
- **CNNA (culture-negative, PMN ≥250) = treat as SBP** (culture may be false negative)
- **Polymicrobial or anaerobes = secondary peritonitis** (NOT SBP) → CT + surgery consult
- **Repeat paracentesis at 48h** (PMN should ↓ by ≥25%)
- **Primary prophylaxis if low ascitic protein (<1.5 g/dL) + advanced cirrhosis**
- **Secondary prophylaxis MANDATORY** after first SBP (norfloxacin 400 mg PO daily indefinitely)
- **69% recurrence at 1 year** without prophylaxis
- **High mortality:** 20-40% in-hospital, 50-70% at 1 year
- **SBP = indication for liver transplant evaluation**
- **Paracentesis safe** even with INR >2 or platelets <50,000 (do NOT need to correct)

**Media:** None

**Sources:** [AASLD 2021 - Ascites and SBP Guidelines], [Hepatology 2024 - SBP management update], [NEJM 2023 - Spontaneous bacterial peritonitis], [Clinical Gastroenterology & Hepatology 2024 - Albumin in SBP], [Gut 2024 - SBP prophylaxis strategies]
